Dr. Hewatt M Sims, MD Orthopaedic Surgery - Orthopaedic Surgery of the Spine Medicare: Accepting Medicare Assignments Practice Location: 100 Doctors Dr Ste F, Douglas, GA 31533 Phone: 912-383-6575 Fax: 912-383-6476 |
Dr. Kenneth P Depersio, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 100 Doctors Dr Ste F, Douglas, GA 31533 Phone: 912-383-6575 Fax: 912-383-6476 |
Dr. Laura L Tharp, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Doctors Dr, Suite 204, Douglas, GA 31533 Phone: 912-383-6575 Fax: 912-383-6476 |
Dr. Stephen John Augustine, D.O. Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Doctors Dr Ste I, Douglas, GA 31533 Phone: 912-383-6575 Fax: 912-383-6476 |
Joshua Landon Vickers, Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 100 Doctors Dr Ste I, Douglas, GA 31533 Phone: 912-383-6575 Fax: 912-383-6476 |
Dr. W Eric Macleod, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 100 Doctors Drive, Suite 101, Douglas, GA 31533 Phone: 912-383-6575 Fax: 912-383-6476 |
Dr. James William Barber, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 110 Shirley Avenue, Douglas, GA 31533 Phone: 912-383-9789 Fax: 912-383-9435 |
News Archive
Illumina, Inc. today announced that it has begun shipping its new HumanOmni2.5-Quad DNA Analysis BeadChip (Omni2.5). This microarray contains millions of newly discovered genome-wide common and rare variants from the 1,000 Genomes Project (1kGP), selected to maximize its ability to detect new associations.
UK charity Heart Valve Voice today launches its report, ‘Towards a Heart Healthy Future: a 2020 Vision for Heart Valve Disease' at a parliamentary event attended by MPs across the country.
Population Genetics Technologies Ltd., creator of innovative methods for genetic analyses and biomarker discovery, has successfully completed a pilot study to prove that its GenomePooling™ method is sensitive and accurate enough to detect even small percentages of gene variants within cancer tissue.
Aegerion Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of cardiovascular and metabolic disease, today announced additional data from its ongoing Phase III trial involving its lead cholesterol management compound, lomitapide (AEGR-733), which is a microsomal triglyceride transfer protein (MTP) inhibitor small molecule drug.
The coauthors of The Independent Budget (IB)—AMVETS, Disabled American Veterans, Paralyzed Veterans of America and Veterans of Foreign Wars who collectively represent millions of veterans—are applauding the Administration's recently released Budget Request for FY 2011. The budget request includes significant funding increases for Department of Veterans Affairs (VA) health care and benefits, and for the first time, advance appropriation recommendations for the VA FY 2012 budget.
› Verified 3 days ago